S Horgan, C A Pellegrini. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Botulinum Toxins, Type A/administration & dosageBotulinum Toxins, Type A/therapeutic useCatheterizationEsophageal Achalasia/epidemiologyEsophageal Achalasia/therapyHumansNeuromuscular Agents/administration & dosageNeuromuscular Agents/therapeutic useRecurrence
Substances: See more » Neuromuscular AgentsBotulinum Toxins, Type A
Year: 1999 PMID: 10022619 DOI: 10.1111/j.1572-0241.1999.00300.x
Source DB: PubMed Journal: Am J Gastroenterol ISSN: 0002-9270 Impact factor: 10.864